Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (341-350 of 743) with videos related to

Pageof 75
Sort By:
Pediatric Dermatology|February 26, 2013
Dermatofibrosarcoma protuberans in childhood treated with slow Mohs micrographic surgeryMarjam J Barysch, Lisa Weibel, Kathrin Neuhaus, et al.
Journal of Dermatological Science|March 4, 2014
Metastatic melanoma cell lines do not secrete IL-1β but promote IL-1β production from macrophagesSamuel Gehrke, Atsushi Otsuka, Roman Huber, et al.
Cancer Cell|January 22, 2021
Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspectiveEgle Ramelyte, Aizhan Tastanova, Zsolt Balázs, et al.
ESMO Open|August 11, 2018
Phase I, open-label study of pasireotide in patients with <i>BRAF-</i>wild type and <i>NRAS</i>-wild type, unresectable and/or metastatic melanomaReinhard Dummer, Olivier Michielin, Mirjam Chantal Nägeli, et al.
Cancers|July 9, 2022
Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. <i>Cancers</i> 2021, <i>13</i>, 3830Ken Kudura, Florentia Dimitriou, Lucas Basler, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2018
MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patientsMichael Constantin Kirchberger, Selma Ugurel, Johanna Mangana, et al.
Cancers|August 7, 2021
Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma PatientsKen Kudura, Florentia Dimitriou, Lucas Basler, et al.
The Oncologist|June 1, 2017
Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic MelanomaSimon Bossart, Selina Thurneysen, Elisabeth Rushing, et al.
Nature Communications|December 8, 2011
Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell responseMaria Antsiferova, Marcel Huber, Michael Meyer, et al.
Clinical Proteomics|March 16, 2018
Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastasesNina Zila, Andrea Bileck, Besnik Muqaku, et al.
Pageof 75

Showing results (341-350 of 743) with videos related to

Sort By:
Pageof 75
Pediatric Dermatology|February 26, 2013
Dermatofibrosarcoma protuberans in childhood treated with slow Mohs micrographic surgeryMarjam J Barysch, Lisa Weibel, Kathrin Neuhaus, et al.
Journal of Dermatological Science|March 4, 2014
Metastatic melanoma cell lines do not secrete IL-1β but promote IL-1β production from macrophagesSamuel Gehrke, Atsushi Otsuka, Roman Huber, et al.
Cancer Cell|January 22, 2021
Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspectiveEgle Ramelyte, Aizhan Tastanova, Zsolt Balázs, et al.
ESMO Open|August 11, 2018
Phase I, open-label study of pasireotide in patients with <i>BRAF-</i>wild type and <i>NRAS</i>-wild type, unresectable and/or metastatic melanomaReinhard Dummer, Olivier Michielin, Mirjam Chantal Nägeli, et al.
Cancers|July 9, 2022
Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. <i>Cancers</i> 2021, <i>13</i>, 3830Ken Kudura, Florentia Dimitriou, Lucas Basler, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2018
MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patientsMichael Constantin Kirchberger, Selma Ugurel, Johanna Mangana, et al.
Cancers|August 7, 2021
Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma PatientsKen Kudura, Florentia Dimitriou, Lucas Basler, et al.
The Oncologist|June 1, 2017
Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic MelanomaSimon Bossart, Selina Thurneysen, Elisabeth Rushing, et al.
Nature Communications|December 8, 2011
Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell responseMaria Antsiferova, Marcel Huber, Michael Meyer, et al.
Clinical Proteomics|March 16, 2018
Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastasesNina Zila, Andrea Bileck, Besnik Muqaku, et al.
Pageof 75